BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 18286571)

  • 1. IRAK4 in TLR/IL-1R signaling: possible clinical applications.
    Li X
    Eur J Immunol; 2008 Mar; 38(3):614-8. PubMed ID: 18286571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity.
    Kim TW; Staschke K; Bulek K; Yao J; Peters K; Oh KH; Vandenburg Y; Xiao H; Qian W; Hamilton T; Min B; Sen G; Gilmour R; Li X
    J Exp Med; 2007 May; 204(5):1025-36. PubMed ID: 17470642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of IRAK4 and IRF3 in the control of intracellular infection with Chlamydia pneumoniae.
    Trumstedt C; Eriksson E; Lundberg AM; Yang TB; Yan ZQ; Wigzell H; Rottenberg ME
    J Leukoc Biol; 2007 Jun; 81(6):1591-8. PubMed ID: 17360955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound.
    Loiarro M; Capolunghi F; Fantò N; Gallo G; Campo S; Arseni B; Carsetti R; Carminati P; De Santis R; Ruggiero V; Sette C
    J Leukoc Biol; 2007 Oct; 82(4):801-10. PubMed ID: 17548806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kinase activities of interleukin-1 receptor associated kinase (IRAK)-1 and 4 are redundant in the control of inflammatory cytokine expression in human cells.
    Song KW; Talamas FX; Suttmann RT; Olson PS; Barnett JW; Lee SW; Thompson KD; Jin S; Hekmat-Nejad M; Cai TZ; Manning AM; Hill RJ; Wong BR
    Mol Immunol; 2009 Apr; 46(7):1458-66. PubMed ID: 19181383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4.
    Suzuki N; Suzuki S; Duncan GS; Millar DG; Wada T; Mirtsos C; Takada H; Wakeham A; Itie A; Li S; Penninger JM; Wesche H; Ohashi PS; Mak TW; Yeh WC
    Nature; 2002 Apr; 416(6882):750-6. PubMed ID: 11923871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3.
    Huang Q; Yang J; Lin Y; Walker C; Cheng J; Liu ZG; Su B
    Nat Immunol; 2004 Jan; 5(1):98-103. PubMed ID: 14661019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKC-alpha controls MYD88-dependent TLR/IL-1R signaling and cytokine production in mouse and human dendritic cells.
    Langlet C; Springael C; Johnson J; Thomas S; Flamand V; Leitges M; Goldman M; Aksoy E; Willems F
    Eur J Immunol; 2010 Feb; 40(2):505-15. PubMed ID: 19950169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 1/Toll-like receptor-induced autophosphorylation activates interleukin 1 receptor-associated kinase 4 and controls cytokine induction in a cell type-specific manner.
    Cushing L; Stochaj W; Siegel M; Czerwinski R; Dower K; Wright Q; Hirschfield M; Casanova JL; Picard C; Puel A; Lin LL; Rao VR
    J Biol Chem; 2014 Apr; 289(15):10865-10875. PubMed ID: 24567333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2.
    Kawagoe T; Sato S; Matsushita K; Kato H; Matsui K; Kumagai Y; Saitoh T; Kawai T; Takeuchi O; Akira S
    Nat Immunol; 2008 Jun; 9(6):684-91. PubMed ID: 18438411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solving the IRAK-4 enigma: application of kinase-dead knock-in mice.
    Koziczak-Holbro M; Joyce C; Glück A; Kinzel B; Müller M; Gram H
    Ernst Schering Found Symp Proc; 2007; (3):63-82. PubMed ID: 18510099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRAK4 as a molecular target in the amelioration of innate immunity-related endotoxic shock and acute liver injury by chlorogenic acid.
    Park SH; Baek SI; Yun J; Lee S; Yoon DY; Jung JK; Jung SH; Hwang BY; Hong JT; Han SB; Kim Y
    J Immunol; 2015 Feb; 194(3):1122-30. PubMed ID: 25548221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling.
    Flannery S; Bowie AG
    Biochem Pharmacol; 2010 Dec; 80(12):1981-91. PubMed ID: 20599782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and optimization of indolo[2,3-c]quinoline inhibitors of IRAK4.
    Tumey LN; Boschelli DH; Bhagirath N; Shim J; Murphy EA; Goodwin D; Bennett EM; Wang M; Lin LL; Press B; Shen M; Frisbie RK; Morgan P; Mohan S; Shin J; Rao VR
    Bioorg Med Chem Lett; 2014 May; 24(9):2066-72. PubMed ID: 24726805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of dysfunction of human variants of the IRAK4 kinase and a role for its kinase activity in interleukin-1 receptor signaling.
    De S; Karim F; Kiessu E; Cushing L; Lin LL; Ghandil P; Hoarau C; Casanova JL; Puel A; Rao VR
    J Biol Chem; 2018 Sep; 293(39):15208-15220. PubMed ID: 30115681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling.
    De Nardo D; Balka KR; Cardona Gloria Y; Rao VR; Latz E; Masters SL
    J Biol Chem; 2018 Sep; 293(39):15195-15207. PubMed ID: 30076215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Toll-like receptor-induced chemokine production in murine dendritic cells by mitogen-activated protein kinases.
    Mitchell D; Olive C
    Mol Immunol; 2010 Jul; 47(11-12):2065-73. PubMed ID: 20451253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRAK4 kinase activity is not required for induction of endotoxin tolerance but contributes to TLR2-mediated tolerance.
    Xiong Y; Pennini M; Vogel SN; Medvedev AE
    J Leukoc Biol; 2013 Aug; 94(2):291-300. PubMed ID: 23695305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic ablation of IRAK4 kinase activity inhibits vascular lesion formation.
    Rekhter M; Staschke K; Estridge T; Rutherford P; Jackson N; Gifford-Moore D; Foxworthy P; Reidy C; Huang XD; Kalbfleisch M; Hui K; Kuo MS; Gilmour R; Vlahos CJ
    Biochem Biophys Res Commun; 2008 Mar; 367(3):642-8. PubMed ID: 18190779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7.
    Bobacz K; Sunk IG; Hofstaetter JG; Amoyo L; Toma CD; Akira S; Weichhart T; Saemann M; Smolen JS
    Arthritis Rheum; 2007 Jun; 56(6):1880-93. PubMed ID: 17530716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.